In December, the nine startups who participated in MassBio’s MassCONNECT mentorship program throughout the year joined together for a final showcase and reception. The 4th Annual NewCo Showcase and Reception was held at the Cooley offices in Boston and gave entrepreneurs a chance to present their updated pitches after eight to ten weeks of working with mentor teams of seasoned industry professionals. The night concluded with a reception where attendees enjoyed cocktails, hors d’oeuvres and 15 second company pitches from the entrepreneurs. Thank you to all who joined us for this festive event in spite of some unfavorable snowy weather conditions! MassCONNECT will start up for 2014 soon so stay tuned!
We have shared some information about the 2013 entrepreneurs on the blog throughout the year, but we wanted to take a chance to share some photos and highlights from the final showcase and present the 2013 class of MassCONNECT graduates:
AblaCor Medical is a medical device company that is developing a revolutionary ablation product called the CircumBlator™ PVI Ablation System for the treatment of patients with atrial fibrillation (AFib). The CircumBlator’s comprehensive solution will provide safer, shorter, easier-to-perform, and more effective catheter ablation procedures.
LuminaCare Solutions is a Healthcare IT Company focused on patient data for optimization of clinical trials. LuminaCare’s lead technology is a platform that integrates patient characteristics, clinical data, and testing algorithms to provide personalized dosing for patients to maintain efficacy while reducing side effects.
Boston 3T Biotechnologies
Boston 3T Biotechnologies is developing genetically engineered T-cells as therapeutic for treating lymphomas and solid tumors. The therapeutic mechanism is based on the mobilization of the patient’s own immune cells, which will lead to the killing of the cancer cells.
Pattern Genomics has developed a novel software platform called Daydreamer that enables simultaneous pattern analysis and molecular assay design based on large-scale DNA sequencing data.
Nivarta is an early stage drug discovery company that is focused on identifying novel gut secreted proteins that are involved in gastric bypass surgery mediated alleviation of diabetes and weight loss.
AWARE Engineering, LLC
The Aware Engineering IHP integrates the various CF health management equipment and components like a pill organizer, a medical grade air compressor, a medical grade steam sterilizer, a medical grade refrigerator, and a chest physical therapy or compression vest system – all of which are required for compliance with state-of-the-art CF therapy.
Transpore Technologies is a niche research and discovery biotechnology company that has developed an innovative drug delivery solution to enable and accelerate testing of new classes of intracellular therapeutics that are not cell permeable.
MyoSyntax uses a novel muscle diagnostic to identify over the counter supplements and FDA approved compounds for personalized decision support to maintain muscle health span and counter muscle wasting.
Cocoon Biotech’s patented technology is an innovative biomaterial that can be injected into the knee joint to provide long lasting joint pain relief.
iOmics Corporation is developing an exciting bioinformatics (molecular biology & computer science) based platform technology within the personalized medicine space. The FUSION platform utilizes Artificial Intelligence (AI) based techniques to improve diagnostic/prognostic accuracy of next generation sequencing and related bioassay technologies.
Investigators have created a 3D machine vision system that reveals the actions and action assembly statistics that define the behaviorome via depth cameras to image and capture the 3D morphology of a mouse in real-time as it behaves.
The night concluded with a reception where attendees enjoyed cocktails, hors d’oeuvres and 15 second company pitches from the entrepreneurs. Thank you to all who joined us for this festive event in spite of some unfavorable snowy weather conditions!